APA (7th ed.) Citation

Ohnmacht, A. J., Stahler, A., Stintzing, S., Modest, D. P., Holch, J. W., Westphalen, C. B., . . . Menden, M. P. (2023). The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nature Communications, 14(1), . https://doi.org/10.1038/s41467-023-41011-4

Chicago Style (17th ed.) Citation

Ohnmacht, Alexander J., et al. "The Oncology Biomarker Discovery Framework Reveals Cetuximab and Bevacizumab Response Patterns in Metastatic Colorectal Cancer." Nature Communications 14, no. 1 (2023). https://doi.org/10.1038/s41467-023-41011-4.

MLA (9th ed.) Citation

Ohnmacht, Alexander J., et al. "The Oncology Biomarker Discovery Framework Reveals Cetuximab and Bevacizumab Response Patterns in Metastatic Colorectal Cancer." Nature Communications, vol. 14, no. 1, 2023, https://doi.org/10.1038/s41467-023-41011-4.